Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles

Christopher D. Warrington Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108.

Search for other papers by Christopher D. Warrington in
Current site
Google Scholar
PubMed
Close
 DVM
,
Daniel A. Feeney Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108.

Search for other papers by Daniel A. Feeney in
Current site
Google Scholar
PubMed
Close
 DVM, MS
,
Christopher P. Ober Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108.

Search for other papers by Christopher P. Ober in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Carl R. Jessen Department of Veterinary Clinical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108.

Search for other papers by Carl R. Jessen in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
,
Susan M. Steward Veterinary Medical Center, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108.

Search for other papers by Susan M. Steward in
Current site
Google Scholar
PubMed
Close
,
Aníbal G. Armién Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108.

Search for other papers by Aníbal G. Armién in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
, and
Thomas F. Fletcher Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108.

Search for other papers by Thomas F. Fletcher in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective—To determine relative concentrations of selected major brain tissue metabolites and their ratios and lobar variations by use of 3-T proton (hydrogen 1 [1H]) magnetic resonance spectroscopy (MRS) of the brain of healthy dogs.

Animals—10 healthy Beagles.

Procedures—3-T 1H MRS at echo times of 144 and 35 milliseconds was performed on 5 transverse slices and 1 sagittal slice of representative brain lobe regions. Intravoxel parenchyma was classified as white matter, gray matter, or mixed (gray and white) and analyzed for relative concentrations (in arbitrary units) of N-acetylaspartate (NAA), choline, and creatine (ie, height at position of peak on MRS graph) as well as their ratios (NAA-to-choline, NAA-to-creatine, and choline-to-creatine ratios). Peak heights for metabolites were compared between echo times. Peak heights for metabolites and their ratios were correlated and evaluated among matter types. Yield was calculated as interpretable voxels divided by available lobar voxels.

Results—Reference ranges of the metabolite concentration ratios were determined at an echo time of 35 milliseconds (NAA-to-choline ratio, 1.055 to 2.224; NAA-to-creatine ratio, 1.103 to 2.161; choline-to-creatine ratio, 0.759 to 1.332) and 144 milliseconds (NAA-to-choline ratio, 0.687 to 1.788; NAA-to-creatine ratio, 0.984 to 2.044; choline-to-creatine ratio, 0.828 to 1.853). Metabolite concentration ratios were greater in white matter than in gray matter. Voxel yields ranged from 43% for the temporal lobe to 100% for the thalamus.

Conclusions and Clinical Relevance—Metabolite concentrations and concentration ratios determined with 3-T 1H MRS were not identical to those in humans and were determined for clinical and research investigations of canine brain disease.

Abstract

Objective—To determine relative concentrations of selected major brain tissue metabolites and their ratios and lobar variations by use of 3-T proton (hydrogen 1 [1H]) magnetic resonance spectroscopy (MRS) of the brain of healthy dogs.

Animals—10 healthy Beagles.

Procedures—3-T 1H MRS at echo times of 144 and 35 milliseconds was performed on 5 transverse slices and 1 sagittal slice of representative brain lobe regions. Intravoxel parenchyma was classified as white matter, gray matter, or mixed (gray and white) and analyzed for relative concentrations (in arbitrary units) of N-acetylaspartate (NAA), choline, and creatine (ie, height at position of peak on MRS graph) as well as their ratios (NAA-to-choline, NAA-to-creatine, and choline-to-creatine ratios). Peak heights for metabolites were compared between echo times. Peak heights for metabolites and their ratios were correlated and evaluated among matter types. Yield was calculated as interpretable voxels divided by available lobar voxels.

Results—Reference ranges of the metabolite concentration ratios were determined at an echo time of 35 milliseconds (NAA-to-choline ratio, 1.055 to 2.224; NAA-to-creatine ratio, 1.103 to 2.161; choline-to-creatine ratio, 0.759 to 1.332) and 144 milliseconds (NAA-to-choline ratio, 0.687 to 1.788; NAA-to-creatine ratio, 0.984 to 2.044; choline-to-creatine ratio, 0.828 to 1.853). Metabolite concentration ratios were greater in white matter than in gray matter. Voxel yields ranged from 43% for the temporal lobe to 100% for the thalamus.

Conclusions and Clinical Relevance—Metabolite concentrations and concentration ratios determined with 3-T 1H MRS were not identical to those in humans and were determined for clinical and research investigations of canine brain disease.

Contributor Notes

Dr. Warrington's present address is Pittsburgh Veterinary Specialty and Emergency Center, 807 Camp Horne Rd, Pittsburgh, PA 15237.

Supported by the Resident Research Grant Award from the American College of Veterinary Radiology (2010) and the Small Companion Animal Research Grant from the College of Veterinary Medicine, University of Minnesota (2010).

Address correspondence to Dr. Feeney (feene001@umn.edu).
  • 1. Howe FA, Opstad KS. 1H MR spectroscopy of brain tumours and masses. NMR Biomed 2003; 16:123131.

  • 2. Barker PB, Bizzi A, De Stefano N, et al. Introduction to MR spectroscopy in vivo. In: Clinical MR spectroscopy: techniques and applications. New York: Cambridge University Press, 2010;114.

    • Search Google Scholar
    • Export Citation
  • 3. Soares DP, Law M. Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 2009; 64:1221.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4. Teresi LM. Introduction and technique. In: A practicing radiologist guide to MR spectroscopy of the brain. Bloomington, Ind: Xlibris Corp, 2007;1420.

    • Search Google Scholar
    • Export Citation
  • 5. Katz-Brull R, Lavin PT, Lenkinski RE. Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions. J Natl Cancer Inst 2002; 94:11971203.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6. Kurhanewicz J, Vigneron DB, Males RG, et al. The prostate: MR imaging and spectroscopy. Present and future. Radiol Clin North Am 2000; 38:115138.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7. Fayad LM, Barker PB, Jacobs MA, et al. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy. AJR Am J Roentgenol 2007; 188:15131520.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 8. Dowling C, Bollen AW, Noworolski SM, et al. Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 2001; 22:604612.

    • Search Google Scholar
    • Export Citation
  • 9. Foerster BR, Thurnher MM, Malani PN, et al. Intracranial infections: clinical and imaging characteristics. Acta Radiol 2007; 48:875893.

  • 10. Barker PB, Gillard JH, van Zijl PCM, et al. Acute stroke: evaluation with serial proton MR spectroscopic imaging. Radiology 1994; 192:723732.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11. Grover VP, Dresner MA, Forton DM, et al. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol 2006; 12:29692978.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12. Sajja BR, Wolinsky JS, Narayana PA. Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am 2009; 19:4558.

  • 13. Soher BJ, Doraiswamy PM, Charles HC. A review of 1H MR spectroscopy findings in Alzheimer's disease. Neuroimaging Clin N Am 2005; 15:847852.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14. Sudharshan N, Hanstock C, Hui B, et al. Degeneration of the mid-cingulate cortex in amyotrophic lateral sclerosis detected in vivo with MR spectroscopy. AJNR Am J Neuroradiol 2011; 32:403407.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15. Kang BT, Jang DP, Lee JH, et al. Detection of cerebral metabolites in a canine model of ischemic stroke using 1H magnetic resonance spectroscopy. Res Vet Sci 2009; 87:300306.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16. Barreiro CJ, Williams JA, Fitton TP, et al. Noninvasive assessment of brain injury in a canine model of hypothermic circulatory arrest using magnetic resonance spectroscopy. Ann Thorac Surg 2006; 81:15931598.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17. Lescot T, Fulla-Oller L, Po C, et al. Temporal and regional changes after focal traumatic brain injury. J Neurotrauma 2010; 27:8594.

  • 18. Signoretti S, Di Pietro V, Vagnozzi R, et al. Transient alterations of creatine, creatine phosphate, N-acetylaspartate and high-energy phosphates after mild traumatic brain injury in the rat. Mol Cell Biochem 2010; 333:269277.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19. Ober CP, Warrington CW, Feeney DA, et al. Optimizing a protocol for 1H-magnetic resonance spectroscopy of the canine brain at 3T. Vet Radiol Ultrasound 2013; 54:149158.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20. Kim JH, Chang KH, Na DG, et al. Comparison of 1.5T and 3T 1H MR spectroscopy for human brain tumors. Korean J Radiol 2006; 7:156161.

  • 21. Hattingen E, Pilatus U, Franz K, et al. Evaluation of optimal echo time for 1H-spectroscopic imaging of brain tumors at 3 Tesla. J Magn Reson Imaging 2007; 26:427431.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22. Hattingen E, Lanfermann H, Quick J, et al. 1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours. MAGMA 2009; 22:3341.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23. Beitz AJ, Fletcher TF. The brain. In: Evans H, ed. Miller's anatomy of the dog. Philadelphia: WB Saunders Co, 1993;894946.

  • 24. Dyce KM, Sack WO, Wensing CJG, et al. The nervous system. In: Textbook of veterinary anatomy. Philadelphia: WB Saunders Co, 2002;271286.

    • Search Google Scholar
    • Export Citation
  • 25. Träber F, Block W, Lamerichs R, et al. 1H metabolite relaxation times at 3.0 Tesla. Measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 2004; 19:537545.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26. Fayed N, Modrego PJ, Medrano J. Comparative test-retest reliability of metabolite values assessed with magnetic resonance spectroscopy of the brain. The LC model versus the manufacturer software. Neurol Res 2009; 31:472477.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27. Maudsley AA, Domenig C, Govind V, et al. Mapping of brain metabolite distributions by volumetric proton MR spectroscopy imaging (MRSI). Magn Reson Med 2009; 61:548559.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28. Li BS, Wang H, Gonen O. Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy. Magn Reson Imaging 2003; 21:923928.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29. Gu M, Spielman DM. B1 and T1 insensitive water and lipid suppression using optimized multiple frequency-selective preparation pulses for whole-brain 1H magnetic resonance spectroscopy at 3T. Magn Reson Med 2009; 61:462466.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30. Lin Y, Gu T, Chen Z, et al. High-resolution MRS in the presence of field inhomogeneity via intermolecular double quantum coherences on a 3-T whole-body scanner. Magn Reson Med 2010; 63:303311.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31. Guerrini L, Belli G, Mazzoli L, et al. Impact of cerebrospinal fluid contamination on brain metabolites evaluation with 1H-MR spectroscopy: a single voxel study of the cerebellar vermis in patients with degenerative ataxias. J Magn Reson Imaging 2009; 30:1117.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32. van der Graaf M, Julià-Sapé M, Howe FA, et al. MRS quality assessment in a multicentre study on MRS-based classification of brain tumours. NMR Biomed 2008; 21:148158.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 33. Neppl R, Nguyen CM, Bowen W, et al. In vivo detection of postictal perturbations of cerebral metabolism by use of proton MR spectroscopy: preliminary results in a canine model of prolonged generalized seizures. AJNR Am J Neuroradiol 2001; 22:19331943.

    • Search Google Scholar
    • Export Citation
  • 34. Jansen JFA, Backes WH, Nicolay K, et al. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006; 240:318332.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35. Smith JK, Castillo M, Kwock L. MR spectroscopy of brain tumors. Magn Reson Imag Clin North Am 2003; 11:415429.

  • 36. Tran T, Ross B, Lin A. Magnetic resonance spectroscopy in neurological diagnosis. Neurol Clin 2008; 27:2160.

  • 37. Chiang IC, Hsieh TJ, Chiu ML, et al. Distinction between pyogenic brain abscess and necrotic brain tumor using 3-Tesla MR spectroscopy, diffusion and perfusion imaging. Br J Radiol 2009; 82:813820.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 38. Hajek M, Krsek P, Dezortova M, et al. 1H MR spectroscopy in histopathological subgroups of mesial temporal lobe epilepsy. Eur Radiol 2009; 19:400408.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 39. King AD, Yeong DK, Yu K, et al. Monitoring treatment response after chemoradiotherapy for head and neck cancer using 1H MR spectroscopy. Eur Radiol 2010; 20:165172.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 40. Lai PH, Weng HH, Chen CY, et al. In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging. AJNR Am J Neuroradiol 2008; 29:15111518.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 41. Majos C, Aguilera C, Alonso J, et al. Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses. AJNR Am J Neuroradiol 2009; 30:544551.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 42. Pal D, Bhattacharyya A, Husain M, et al. In vivo proton MR spectroscopy evaluation of pyogenic brain abscesses: a report of 194 cases. AJNR Am J Neuroradiol 2010; 31:360366.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement